Concepedia

Author

Petr Kujal

Institute of Clinical and Experimental Medicine

Also Known As

Kujal, P., P Kujal, P. KUJAL, P. Kujal, Petr Kujal

44

Publications

622

Citations

15

H-Index

47

Concepts

All Affiliations

Institute of Clinical and Experimental MedicineCharles UniversityUniversity of BonnMossakowski Medical Research Institute, Polish Academy of SciencesCzech Academy of Sciences, Institute of Physiology
PK

About

Petr Kujal is an author at Institute of Clinical and Experimental Medicine specializing in medicine, hypertension, and physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

278

2

Biochemistry

2

2

82

3

Engineering

1

1

19

4

Kinesiology

1

1

19

5

Metabolism

1

1

37

Petr Kujal

×

22

Publications

565

Citations

15

H-Index

YearCitations

Intrapulmonary Activation of the Angiotensin-Converting Enzyme Type 2/Angiotensin 1-7/G-Protein-Coupled Mas Receptor Axis Attenuates Pulmonary Hypertension in Ren-2 Transgenic Rats Exposed to Chronic Hypoxia

Václav Hampl, Jan Herget, Alena Baňasová,

Physiological Research

2015

71

[5/6 nephrectomy as an experimental model of chronic renal failure and adaptation to reduced nephron number].

Petr Kujal, Z Vernerová

PubMed

2008

46

Combined inhibition of 20-hydroxyeicosatetraenoic acid formation and of epoxyeicosatrienoic acids degradation attenuates hypertension and hypertensioninduced end-organ damage in Ren-2 transgenic rats

Věra Čertíková Chábová, Agnieszka Walkowska, Elżbieta Kompanowska‐Jezierska,

Clinical Science

2010

45

Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren‐2 transgenic hypertensive rats

Petr Kujal, Věra Čertíková Chábová, Petra Škaroupková,

Clinical and Experimental Pharmacology and Physiology

2014

37

Inhibition of soluble epoxide hydrolase improves the impaired pressure–natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats

Zuzana Honetschlägerová, Alexandra Sporková, Libor Kopkan,

Journal of Hypertension

2011

36

Similar renoprotection after renin‐angiotensin‐dependent and ‐independent antihypertensive therapy in 5/6‐nephrectomized Ren‐2 transgenic rats: are there blood pressure‐independent effects?

Petr Kujal, Věra Čertíková Chábová, Zdeňka Vernerová,

Clinical and Experimental Pharmacology and Physiology

2010

33

Effects of Combined Endothelin A Receptor and Renin-Angiotensin System Blockade on the Course of End-Organ Damage in 5/6 Nephrectomized Ren-2 Hypertensive Rats

Ivana Vaněčková, Petr Kujal, Zuzana Husková,

Kidney & Blood Pressure Research

2012

32

Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats

Dan Rakušan, Petr Kujal, Herbert J. Kramer,

American Journal of Physiology-Renal Physiology

2010

27

Soluble Epoxide Hydrolase Inhibition Exhibits Antihypertensive Actions Independently of Nitric Oxide in Mice with Renovascular Hypertension

Libor Kopkan, Zuzana Husková, Alexandra Sporková,

Kidney & Blood Pressure Research

2012

26

Addition of ETA receptor blockade increases renoprotection provided by renin–angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats

Věra Čertíková Chábová, Zdeňka Vernerová, Petr Kujal,

Life Sciences

2013

25

Page 1